Aromatherapy for Integrated Cancer CareResearch Question:
Does aromatherapy provide symptom relief experienced during chemotherapy?
Basic Study Information
Purpose:Location: University of Rochester Medical Center, Wilmot Canter Center
The purpose of this clinical trial is to determine the feasibility and effectiveness
of aromatherapy in relief of commonly reported symptoms in cancer patients undergoing
chemotherapy. Aromatherapy is a noninvasive, minimal risk intervention that could
potentially alleviate the severity of treatment-related symptoms. This study will
evaluate the ability of four aromatherapy scents (ginger, lavender, orange, jojoba)
to reduce the severity of seven chemotherapy-induced symptoms (nausea, vomiting, pain,
anxiety/distress, fatigue, sleep difficulties, and lack of appetite). As part of the
study, the participants will be asked to use an aromatherapy inhaler, which resembles
a lipstick container, during three chemotherapy cycles. The participants will use
the aromatherapy inhaler for 7 consecutive days. The investigators will ask the participants
questions regarding demographics, clinical information, current severity of symptoms,
and current methods of symptom management. There
is a non-intervention baseline cycle during which subjects rate the severity of the
seven different symptoms from 0 to 10 for seven consecutive days during their first
chemotherapy study cycle. The next two study cycles are intervention cycles using
the randomized aromatherapy. The participants will rate the severity of seven different
symptoms from 0 to 10 each day the aromatherapy inhaler during each of the three chemotherapy
cycles (i.e., 7 consecutive days during each chemotherapy cycle). Additionally, participants
will report if they felt the aromatherapy helped with certain symptoms and if he/she
were able to reduce taking extra medications for their symptoms. At the end of the
study, the participants will be asked about his/her satisfaction with the aromatherapy
used during the study. All of these measurements will provide a better understanding
of the effectiveness of aromatherapy for symptom management.
Study Reference #: 00071162
Lead Researcher (Principal Investigator)
Study Contact InformationStudy Coordinator: Madeline Forster
Phone: (585) 695-5533
Additional Study Details
Participants are provided with folders containing the necessary forms for each cycle,
as well as pre-addressed, stamped envelopes to mail in the forms after completion.
Participants can keep the aromatherapy inhaler at the end of the study and are reimbursed
for their participation.
Trial Not Found
The study you are looking for is not active at this time.
Return to Search